| Hepatoblastoma studied in …STUDIED_INderived61 of 61show fewer |
|---|
| → studied in | NCT03210714Phase 2 · active not recruiting Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03698994Phase 2 · active not recruiting Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03533582Phase 3 · active not recruiting Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02867592Phase 2 · active not recruiting Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04851119Phase 1/Phase 2 · recruiting Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors · condition mapped CURATED_BROADER · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03959800recruiting Molecular Basis of Pediatric Liver Cancer · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06822842completed Accurate Diagnosis and Grading of Pediatric Solid Tumors Based on Pathological Large Models · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04320888Phase 2 · active not recruiting Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial · condition mapped CURATED_BROADER · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04337177Phase 1 · active not recruiting Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03155620Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) · condition mapped CURATED_BROADER · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04284774Phase 2 · active not recruiting Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial · condition mapped CURATED_BROADER · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03213652Phase 2 · active not recruiting Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04634357Phase 1/Phase 2 · recruiting ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04195555Phase 2 · active not recruiting Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00980460Phase 3 · completed Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active) | — | — | PRETEXT I Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03213704Phase 2 · active not recruiting Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04897321Phase 1 · recruiting B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04901702Phase 1/Phase 2 · recruiting Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma · condition mapped CURATED_BROADER · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03017326Phase 3 · active not recruiting Paediatric Hepatic International Tumour Trial · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04478292Phase 3 · recruiting A Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04483778Phase 1 · active not recruiting B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03213678Phase 2 · completed Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04308330Phase 1 · recruiting Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06638931Phase 2 · recruiting Agnostic Therapy in Rare Solid Tumors · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03213665Phase 2 · completed Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03526250Phase 2 · completed Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05556642recruiting Relapsed and Refractory Hepatoblastoma: A Prospective Registry and Liver Tumor Research Consortium Initiative · condition mapped CURATED_BROADER · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07148050Phase 1 · recruiting Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07300449Phase 2 · recruiting A Prospective Multicenter Clinical Study of SCCG Protocol and ctDNA 5hmc in Predicting the Chemotherapy Sensitivity and Monitoring the Recurrence and Metastasis of Hepatoblastoma in Children and Adolescents · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03618381Phase 1 · active not recruiting EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06521567Phase 1/Phase 2 · active not recruiting A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06198296Phase 1 · recruiting Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07188311NA · recruiting Pucotenlimab Combined With Lenvatinib and Chemotherapy in the Treatment of Advanced, Relapsed/Refractory Hepatoblastoma in Children · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06541652recruiting A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03220035Phase 2 · completed Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial) · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05302921Phase 2 · completed Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03233204Phase 2 · completed Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04315883terminated Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver Tumors · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05245123completed Psychosocial Situation of Children With Rare Solid Abdominal Tumors and Their Families · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05763173completed Evaluation of Lung Metastases Based on Ultrashort Echo Time MRI · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06190574completed Diagnostic Efficacy and Prognostic Value of 18F-FDG PET/CT (MR) in Pediatric Solid Blastoma · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01505569NA · completed Auto Transplant for High Risk or Relapsed Solid or CNS Tumors · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02557750unknown Combined Modality Therapy in Hepatoblastoma: South Egypt Cancer Institute Experience · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05693519unknown GastroIntestinal Cancer in Children and Adolescents · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05322187Phase 2/Phase 3 · unknown Sequential PD-1/PD-L1 Inhibitor and LENvatinib in TLCT and Refractory Hepatoblastoma After Chemotherapy · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05170282unknown Deep Learning Magnetic Resonance Imaging Radiomics for Diagnostic Value of Hepatic Tumors in Infants · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03645655completed PIVKA-II Combined With Alpha-Fetoprotein for Diagnostic and Prognostic Value of Hepatic Tumors in Infants · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01331135Phase 1 · completed Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04093648Phase 1 · withdrawn T Cells co- Expressing a Second Generation Glypican 3-specific Chimeric Antigen Receptor With Cytokines Interleukin-21 and 15 as Immunotherapy for Patients With Liver Cancer (TEGAR) · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01154816Phase 2 · completed Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02390843Phase 1 · completed Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03728543Phase 2/Phase 3 · unknown the Efficacy and Safety of Sugammadex in Children 0-2 Years Old · condition mapped ALIAS · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02933333Phase 4 · unknown G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02011126Phase 2 · withdrawn Imetelstat Sodium in Treating Younger Patients With Relapsed or Refractory Solid Tumors · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01125800Phase 1/Phase 2 · completed A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01336881completed Biomarkers in Tissue Samples From Young Patients With Liver Cancer · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active) | — | — | Childhood Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00831844Phase 2 · completed Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active) | — | — | Childhood Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00228683NA · withdrawn Hepatoblastoma Biology Study and Tissue Bank · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003994Phase 3 · completed Combination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver Cancer · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active) | — | — | Childhood Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00091182Phase 2 · completed Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active) | — | — | Childhood Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00179816Phase 1/Phase 2 · unknown Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active) | — | — | Hepatoblastoma | 1 | Observed | clinicaltrials | graph → |